Events
Stay up-to-date with the latest events, including faculty presentations, career events for students and alumni, and so much more.
Calendar of Events
S Sun
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
0 events,
2 events,
4 events,
4 events,
1 event,
Pharmacist Career Exploration Day (on-campus event)
Pharmacist Career Exploration Day (on-campus event)
Learn about the field of pharmacy and the variety of career paths available to PharmD graduates.
0 events,
0 events,
0 events,
3 events,
726-640: Appropriate Use of Drugs of Abuse
2 events,
A Specific Cure for Homosexuality: Postwar Psychedelic Conversion Therapies in the United States & Canada
A Specific Cure for Homosexuality: Postwar Psychedelic Conversion Therapies in the United States & Canada
Guest speaker: Andrea Ens, Purdue University. This presentation outlines Canadian and American practitioners’ use of LSD, mescaline, and peyote in psychedelic conversion therapies during the postwar period. Such programs in both countries drew from widespread psychiatric faith in psychoanalysis and pharmacology in changing patient behavior, as well as shared Cold War-era cultural anxieties about sex, gender, and national security that negatively associated same-gender attraction with Communism, criminality, and psychopathy.
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
1 event,
1 event,
0 events,
0 events,
2 events,
3 events,
2022 Kremers Lecture – Dean Julie Johnson, University of Florida College of Pharmacy
2022 Kremers Lecture – Dean Julie Johnson, University of Florida College of Pharmacy
The 2021 Kremers Lecturer is Dr. Julie Johnson, Dean of the University of Florida College of Pharmacy and Distinguished Professor of Pharmacy and Medicine. Her presentation is titled "Improving Clinical Outcomes through Pharmacogenetics."
0 events,
3 events,
Standards without Labs: Psychedelic Drug Development in the Underground
Standards without Labs: Psychedelic Drug Development in the Underground
Guest speaker: Joanna Kempner, Rutgers University. Federal regulations mandate that investigators limit their clinical trials to pre-approved, standardized drugs to assure reliable results. Sometimes, however, unauthorized investigators) develop therapeutic protocols for the use of drugs in the underground, beyond the reach of federal regulators. This presentation investigates how unauthorized investigators engaged in “collective experimentation” standardize drugs given the difficulty of obtaining “laboratory-grade” pharmaceuticals by drawing on a case study of Clusterbusters.
1 event,
0 events,
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.
- There are no events on this day.